COMMUNIQUÉS West-GlobeNewswire

Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America
14/07/2025
WESTBROOK, Maine, July 14, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a fast-growing consumer health and wellness company, today announced a new wave of retail and [...]
Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)
14/07/2025
Premier et seul médicament approuvé par Santé Canada chez les patients âgés d’à peine 6 mois atteints d’HFHo, une forme héréditaire très rare d’hypercholestérolémie TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx [...]
Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
14/07/2025
First and only medicine approved by Health Canada for patients as young as 6-months of age with HoFH, an ultrarare, inherited form of high cholesterol TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical [...]
JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
14/07/2025
IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the [...]
Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
14/07/2025
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief [...]
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
14/07/2025
Interim Phase 3 Results Support Ovaprene’s Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly Contraceptive SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a [...]
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
14/07/2025
New “Decision to grant” communications in Canada and Israel For the treatment of aggression and social withdrawal MADRID and CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
14/07/2025
Company also announces new 500-patient SUMMIT RISE study at the Society of NeuroInterventional Surgery annual meeting SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical [...]
Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3
14/07/2025
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development [...]
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
14/07/2025
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage [...]
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
14/07/2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC ( [...]
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
14/07/2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic
14/07/2025
Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide Therapy TM (PRnT) solutions, today announced the submission of its Investigational Device Exemption (IDE) [...]
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
14/07/2025
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July [...]
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
14/07/2025
Borvo Medical to showcase innovative EVAC™ system at Society of Neurointerventional Surgery Annual Meeting MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical , a neurosurgical medtech startup and a [...]
NEXGEL and STADA AG Announce Expansion of Partnership for North America
14/07/2025
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer [...]
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
14/07/2025
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company [...]
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
14/07/2025
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in [...]
Dr. Anosh Ahmed Foundation Launches Chicago-Based Initiative to Support Families of Fallen FBI Agents and Law Enforcement Officers
14/07/2025
In response to public support and growing community need, the foundation announces a new phase of local engagement and charitable efforts CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Dr. Anosh Ahmed Foundation has [...]

Pages